Medical Marijuana, Inc. Announces April 2019 as the Largest Sales Bookings Month in Company History

SAN DIEGO, May 9, 2019 — Medical Marijuana, Inc. (OTC: MJNA), the first-ever publicly traded cannabis company in the United States, today announced that the company had its the largest-ever (unaudited) sales bookings month in its history in April 2019. The company also reached major milestones in its business operations.

“We are proud to announce our impressive growth in April,” said Medical Marijuana, Inc. CEO Dr. Stuart Titus. “It was just announced by analysts at The Green Fund that the global cannabis industry is positioned to be the world’s most lucrative sector and we’re excited to be at the forefront of cannabidiol (CBD) as a segment of this profitable business.”

The company also achieved significant accomplishments during the month of April including its subsidiary Kannaway® being listed as one of the Top 100 Direct Selling Companies in the world by Direct Selling News, hosting its largest U.S. event – the National Believe Convention, and welcoming athletes such as Paralympic Archer Samantha Tucker and Professional Boxer Austin Trout to its Kannaway® Sports team. Kannaway® also released several exciting new products such as Coffee & Tea Pods, Hemp CBD Gum, CBD cat treats, and an updated version of its Cannabis Beauty Defined™ CBD skincare line.

In addition, Medical Marijuana, Inc. subsidiary Phyto Animal Health released two new products including a topical CBD skin balm and CBD cat treats and subsidiary HempMeds® Brasil hosted a cannabis symposium for Brazilian doctors in San Diego.

Accomplishments also include the portfolio of companies obtaining positive news coverage in several national and international news outlets including Bloomberg, Forbes, The Boston Globe, Fox Business, VICE, Bustle, Who What Wear and more.

About Medical Marijuana, Inc.

We are a company of firsts®. Our mission is to be the premier cannabis and hemp industry innovators, leveraging our team of professionals to source, evaluate and purchase value-added companies and products, while allowing them to keep their integrity and entrepreneurial spirit. We strive to create awareness within our industry, develop environmentally friendly, economically sustainable businesses, while increasing shareholder value. For details on Medical Marijuana, Inc.’s portfolio and investment companies, visit

To see Medical Marijuana, Inc.’s corporate video, click here.

Shareholders and consumers are also encouraged to buy CBD oil and other products at Medical Marijuana, Inc.’s shop.


This press release may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties and other factors, which may cause the actual results, performance or achievements of Medical Marijuana, Inc. to be materially different from the statements made herein.


These statements have not been evaluated by the FDA and are not intended to diagnose, treat or cure any disease.


Medical Marijuana, Inc. does not sell or distribute any products that are in violation of the United States Controlled Substances Act (US.CSA). These companies do grow, sell, and distribute hemp-based products and are involved with the federally legal distribution of medical marijuana-based products within certain international markets. Cannabidiol is a natural constituent of hemp oil.


Public Relations Contact:

Andrew Hard

Chief Executive Officer

CMW Media

P. 858-264-6600

[email protected]